CG Oncology, Inc.
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CGON and other ETFs, options, and stocks.About CGON
CG Oncology, Inc. is a clinical biopharmaceutical company, which engages in the development and commercialization of bladder-sparing therapeutic patients afflicted with bladder cancer. It offers cretostimogene, a product initially in clinical development for the treatment of patients with Non-Muscle Invasive Bladder Cancer (NMIBC).
CGON Key Statistics
Stock Snapshot
The current CG Oncology, Inc.(CGON) stock price is $69.62, with a market capitalization of 5.88B. The stock trades at a price-to-earnings (P/E) ratio of -33.43.
On 2026-05-10, CG Oncology, Inc.(CGON) stock traded between a low of $68.55 and a high of $70.32. Shares are currently priced at $69.62, which is +1.6% above the low and -1.0% below the high.
The CG Oncology, Inc.(CGON)'s current trading volume is 1.14M, compared to an average daily volume of 735.92K.
In the last year, CG Oncology, Inc.(CGON) shares hit a 52-week high of $73.56 and a 52-week low of $23.32.
In the last year, CG Oncology, Inc.(CGON) shares hit a 52-week high of $73.56 and a 52-week low of $23.32.
Analyst ratings
100%
of 15 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.